On November 21, 2024 Dr. Siolas attended the 2024 Cancer Survivors Hall of Fame Dinner and was awarded a grant by the Cancer Research & Treatment Fund, INC.
The mission of the Cancer Research & Treatment Fund (CR&T) is to fund research emphasizing the cause, prvention, treatment and cure of myeloproliferative neoplasms (MPNs) and also other blood and solid tumor cancer research remains steadfast. With ongoing support, the CR&T is excited about the progress being made in both their traditional areas of focus and new frontiers.
This year, the CR&T have continued their dedicated support for physician-scientists and their groundbreaking research into the understanding and treatment of cancer. The CR&T's ongoing commitment to myeloproliferative neoplasms (MPNs) remains strong. Additionally, they have increased their funding for solid tumor cancer research, reflecting their commitment to addressing a broader spectrum of cancer types.
This year, one of their key initiatives is a grant awarded to Despina Siolas, MD, PhD from Weill Cornell Medicine. With the funding provided by CR&T, Dr. Siolas' research goal is to understand how a tumor's DNA makeup can profoundly shape the number and types of immune cells surrounding the tumor. Read more in CR&T newsletter Fall 2024 available at www.crt.org